4 ms·
The short answer is "probably". The use of AI in drug design is only just now starting, we'll see the results in about 10 years. I optimistically expect AI to b
by zinclozenge 8y ago
The short answer is "probably". The use of AI in drug design is only just now starting, we'll see the results in about 10 years. I optimistically expect AI to be able to shave off ~2-3 years of the drug lifecycle.
edit: but it won't do much to optimize P2 trial success specifically, it'll simply help iterate substantially faster in the pre-P2 trial phases.